drugset / Trial / NCT00992160
Vestipitant 28-day Tolerance Study
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is a 28-day polysomnographic and subjective assessment of oral Vestipitant 15mg/day for treatment of Primary Insomnia in adults outpatients.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vestipitant | Small molecule | 15 mg | Oral |